medigraphic.com
Órgano Oficial del Instituto Nacional de Pediatría

2016, Number 2

<< Back Next >>

Acta Pediatr Mex 2016; 37 (2)

Senescent Langerhans cell histiocytosis. Case report

Corcuera-Delgado CT, Garza-Elizondo R, González-Flores L, Velasco- Hidalgo L

Language: Spanish
References: 14
Page: 94-101
PDF size: 738.13 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Arkader A, Glotzbecker M, Hosalkar HS. Primary musculoskeletal Langerhans cell histiocytosis in children: an analysis for a 3-decade period. J Pediatr Orthop. 2009;29:201-207.

  2. Imashuku S, kinugawa N, Matsuzaki A. Langerhans cell histiocytosis with multifocal bone lesions: comparative clinical features between single and multi-systems. Int J Hematol. 2009;90:506-512.

  3. Morimoto A, Ishida Y, Suzuki N. Nationwide survey of single system single site Langerhans cell histiocytosis in Japan. Pediatr Blood Cancer. 2009;54:98-102.

  4. Salotti JA, Nanduri V, Pearce MS. Incidence and clinical features of Langerhans cell histiocytosis in the UK and Ireland. Arch Dis Child. 2009;94:376-380.

  5. Yoon SH, Park SH. A study of 77 cases of surgically excised scalp and skull masses in pediatric patients. Childs Nerv syst. 2008;24:459-465.

  6. Kilpatrick SE, Wenger DE, Gilchrist GS. Langerhans’ cell histiocytosis (histiocytosis X) of bone. A clinicopathologic analysis of 263 pediatric and adult cases. Cancer. 1995;76:2471-2484.

  7. Yagci B, Varan A, Caglar M. Langerhans cell histiocytosis: retrospective analysis of 217 cases in a single center. Pediatr Hematol Oncol. 2008;25:399-408.

  8. Stull MA, Kransdorf MJ, Devaney KO. Langerhans cell histiocytosis of bone. Radiographics. 1992;12:801-823.

  9. Stocker JT, Dehner LP. Pediatric Pathology. Second edition. 2001; volume two: 1364-1366.

  10. Stocker JT, Dehner LP, Husain AN. Pediatric Pathology. Third edition. 2011: 1248-1251.

  11. Zapata-Tarres M, Leal-Leal C, Rodríguez-Jurado R, Rivera Luna R. Histiocitosis de células de Langerhans: experiencia clínica y terapéutica en niños en el Instituto Nacional de Pediatría en 30 años. Boletín Médico del Hospital Infantil de México. 2003;60(1):70-78.

  12. Gadner H, Minkov M, Grois N, Pötschger U, Thiem E, Arico M, et al. Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis. Blood 2013;121:5006-5014

  13. Egeler RM, Kraker J, Voute PA. Cytosine-Arabinoside, Vincristine and Prednisolone in the treatment of children with disseminated Langerhans Cell Histiocytosis with organ dysfunction: experience at a single institution. Medical and Pediatric Oncology 1993;21:265-270.

  14. Morimoto A, Shioda Y, Imamura T, Kanegane H, Sato T, Kudo K, et al. National Survey of Bisphosphonate therapy for children with reactivated Langerhans Cell Histiocytosis in Japan. Pediatr Blood Cancer 2011;56:110-115.




2020     |     www.medigraphic.com